G Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Genpact is not a strong buy right now for a beginner investor with a long-term focus and $50,000-$100,000 to deploy. The business fundamentals are improving, but the current technical setup is still bearish, options sentiment is mixed-to-slightly bullish, and analyst targets are being cut. Since there is no AI Stock Picker or SwingMax buy signal today, I would not buy aggressively at this moment. Best direct call: hold and wait for a better setup rather than buying immediately.
The technical picture is weak in the near term. MACD histogram is negative, though improving slightly, RSI at 45.48 is neutral, and the moving averages are bearish with SMA_200 > SMA_20 > SMA_5. Price at 34.92 is only slightly above S1 at 33.61 and below the pivot at 35.325, which suggests limited immediate upside unless it reclaims the pivot decisively. The short-term pattern data also leans soft, with modest negative next-month expectations.
["Q4 2025 revenue grew 5.65% YoY, showing continued top-line expansion.", "EPS rose 3.80% YoY and gross margin improved to 36%, indicating some operating strength.", "News flow is positive around Genpact\u2019s leadership in the 2026 ServiceNow ecosystem and its AI Gigafactory delivery model.", "Needham kept a Buy rating, suggesting at least one bullish analyst still sees upside.", "Advanced Technology Solutions is a growth driver and continues to support results."]
["Susquehanna cut its price target to $42 from $50 and kept a Neutral rating.", "Needham also lowered its target to $50 from $53, showing reduced near-term optimism.", "Core business growth remains a concern, with analysts explicitly noting that core questions remain.", "Hedge funds are selling, and the selling amount has increased sharply over the last quarter.", "No recent congress trading data or insider buying signal provides additional support.", "Technicals remain bearish, with price below the pivot and trend structure still weak."]
In Q4 2025, Genpact showed steady but not explosive growth. Revenue increased to $1.319 billion, up 5.65% YoY, net income rose 0.83% YoY to $143.1 million, EPS increased 3.80% YoY to $0.82, and gross margin improved to 36%. This is a decent quarter with improving profitability and margin expansion, but it does not yet indicate a major acceleration in growth.
Recent analyst trend is mixed but trending slightly more cautious: Needham kept a Buy rating but reduced its target to $50 from $53, while Susquehanna kept a Neutral rating and cut its target to $42 from $50. The Wall Street pros view is therefore split: bulls point to solid Q4 execution and ATS momentum, while bears focus on slower core business growth and reduced price targets. Net takeaway: supportive, but not enough to justify an aggressive buy today.
